Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Ayurvedic
By Brand Name
By Generic Name
By Therapeutics Class
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Home
About Us
Overview
Vision, Mission & Core Values
History
Founders
Key Promoters & Directors
Management Team
Corporate Governance
Our Recognition
Products
Pharmaceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Herbal & Nutraceuticals
By Brand Name
By Generic Name
By Therapeutics Class
Ayurvedic
By Brand Name
By Generic Name
By Therapeutics Class
Veterinary
By Brand Name
By Generic Name
By Therapeutics Class
Facilities
Overview
R&D
Quality Operations
General Unit
Cephalosporin Unit
BFS, Liquid & Semi-Solid Unit
Solid Dosage Unit
Penicillin Unit
Hormone & Steroid Unit
Herbal & Ayurvedic Unit
Veterinary Unit
Gallery
Photo Gallery
Virtual Tours
CSR
Overview
Commitment to the Employee
Commitment to the Society
Commitment to Environment
Triple Bottom Line (TBL) Reporting
Mass Extinction Crisis
Business Operations
Marketing, Sales & Distribution
Finance and Accounts
Global Presence
HR & Administration
Corporate Affairs
Information Technology
Legal,Regulatory & QMS
Internal Audit
Investors Corner
Corporate Brief
Director's Report
Financial Reports
Price Sensitive Information
Unclaimed Dividend Information
Shareholding Position
Declaration
C G Compliance Status
Code of Conduct
Dividend Distribution Policy
Annual General Meeting
Use of IPO Proceeds
Share Information
Investor Relations Contact
Doctors Corner
Doctors Corner
Customer Feedback
Career
Newsroom/Media
Climate & Environment
Contact Us
Annual General Meeting
Notice
User Guide & Form of Proxy
Notice of 46th Annual General Meeting-2021-2022
Read More
Notice of 45th Annual General Meeting-2020-2021
Read More
Notice of 44th Annual General Meeting-2019-2020
Read More
Notice of 42nd Annual General Meeting-2017-2018
Read More
Notice of 43rd Annual General Meeting-2018-2019
Read More
Notice of 41st Annual General Meeting-2017
Read More
Notice of 40th Annual General Meeting-2016
Read More
Form of Proxy – The 46th Annual General Meeting
Read More
User-Guide-ACME
Read More
